• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Taris Biomedical completes Phase I study of bladder drug-device combo

December 2, 2009 By drugdelivery

Taris Biomedical said it successfully completed the first phase of clinical trials of its drug-device combination to treat bladder problems, but declined to release any details of the study pending scientific publication.

The Lexington, Mass.-based firm said the study of its Liris device, which stands for “lidocaine-releasing intravesical system,” was aimed at evaluating the safety, tolerability and retention of the system in the bladder for treating interstitial cystitis. Also known as painful bladder syndrome, IC involves chronic inflammation of the bladder wall.

Taris COO Christine Bunt said the study establishes proof-of-concept and sets the stage for a Phase II trial of the device next year.

The company launched in June with $15 million in venture fund backing. Taris is an MIT spinoff involving two well-known scientists from the institute, Michael Cima and Robert Langer; Cima is the company’s co-founder and Langer sits on its board.

Langer said the study “opens up the potential of this drug-device convergence system, beyond IC, into a variety of bladder diseases such as bladder cancer and overactive bladder,” according to a press release.

Earlier this month, Taris tapped Julie Lekstrom Himes to be its chief medical officer and lead its clinical development program.

Filed Under: Business/Financial News, Drug-Device Combinations

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS